Continued treatment for teen schizophrenia or bipolar
Part of Mental health clinical trials.
This program lets teens who finished a year-long study keep taking the study medicine (olanzapine/samidorphan) to manage schizophrenia or bipolar I disorder. It may help maintain mood stability and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed 52 weeks in the earlier ALKS 3831-A313 study.
- You need to be safe to live at home with family support.
- Your doctor thinks you would benefit from continuing this medicine.
- You can be treated as an outpatient (not in the hospital).
- You agree to use birth control (if applicable) and avoid pregnancy.
- Your parent or guardian must agree to help you follow the plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how safe a kid’s ongoing treatment is over a longer period. It is mainly for children who already finished a related study and may benefit from continuing the same medicines.
This Phase 3 study tests a treatment aimed at reducing unhealthy weight gain in teens with schizophrenia or bipolar I disorder, using changes in BMI (a height-and-weight measure). It may help families who are concerned about weight changes that can happen with some psychiatric medicines.
This study tests whether a combination of a daily medication (olanzapine-samidorphan) and a structured exercise program can help people with schizophrenia, schizoaffective disorder, or bipolar disorder improve their health and well-being.
This study looks at how well patients with bipolar disorder do while taking the medication olanzapine. You will continue your regular treatment, and answer questions about your experience.
This study tests a new combination pill (olanzapine and samidorphan) for adults with schizophrenia. It aims to see if the combination helps control symptoms while potentially reducing weight gain, which is a common side effect of olanzapine.
This trial tests whether OSU6162 can improve depressive symptoms in adults with bipolar depression who are already taking a stable mood-stabilizing medicine. It also checks safety by closely monitoring mood, heart rhythm, and other health factors during the study.
Hear when a new Bipolar 1 Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.